Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 1c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Zimmer Biomet's (ZBH) strong second quarter tarnished by high expectations
August 1, 2023 12:13 PM EDTShares of medical technology company Zimmer Biomet (NYSE: ZBH) declined after it reported results for the second quarter of 2023. Revenue, earnings per share, and guidance all topped published consensus figures but they were still not enough to meet elevated expectations on Wall Street.
Zimmer Biomet reported second quarter EPS of 1.82, a... More
